Cortechs Labs - Products : NeuroQuantProduct

NeuroQuant^®

NeuroQuant^® is a breakthrough medical device that can make quantitative MRI measurement a routine part of clinical practice. It brings sophisticated, accurate, and fully automated MRI post-processing capabilities to the physician's desktop.
This software provides neurologists, radiologists, and clinical researchers with a convenient and cost-effective means to quantify the volume of the hippocampus and other structures.

NeuroQuant^® takes high-resolution 3D T1-weighted, sagittal, non-contrast-enhanced MRI scan from disk or auto-routed from a scanner or a PACS server as input and in a few minutes, with no user intervention, returns a new full-volume spatially corrected and anatomically labeled dataset along with two printable patient reports containing the absolute and relative volumes of the hippocampus, temporal horn, and other structures in DICOM compliant format.

NeuroQuant^® Output:

Age-Related Atrophy Report contains the absolute and relative volumes of the hippocampus and inferior lateral ventricles, structures that typically show significant atrophy in dementia patients. The resulting values are automatically compared to age-appropriate reference distributions. The interpreting physician can select representative slices and add a comment in the provided text box to be included in the report.
General Morphometry Report provides the absolute and relative volumes for the right- and left-side of the following brain structures: Forebrain Parenchyma, Cortical Gray Matter, Lateral Ventricle, Inferior Lateral Ventricle, Hippocampus, Amygdala, Caudate, Putamen, Pallidum, Thalamus and Cerebellum. It also provides an Asymmetry Index (defined as the difference between left and right volumes divided by their mean).
* Both reports can also be viewed in a web-browser and printed or emailed as PDF files.
Color-coded brain segmentation is provided as a separate 3D MR series for closer inspection on a PACS or other DICOM viewer.
Coronal Loop icon opens up a ‘movie’ of the color-coded segmented brain that can be viewed in QuickTime or Windows Media Player.

NeuroQuant^® Features Include:

Segmentation of MRIs of the whole brain and regional volumetric quantification of structures in less than 15min with no user intervention.
Automatic Correction for image artifacts including gradient nonlinearities and RF field inhomogeneities.
Atlas-Based image registration, anatomical segmentation, and volumetric quantification of the hippocampus, ventricles and other brain structures.
High Validity -- Automated segmentation shown to be highly consistent with that performed by human expert neuroanatomist
High Reliability -- Making results ideal for longitudinal follow-up and tracking of disease.
Numerical Results are automatically compared to normative data to highlight atrophy greater than expected from normal aging.
Medial Temporal lobe volumes from NeuroQuant shown to be sensitive to MCI and early AD in multi-vendor, multi-site MRI data

Compatibility:

Compatible with most modern 1.5T and 3T Siemens, GE ,or Philips MRI scanners.
NeuroQuant^® is currently compatible with Mac OS X and Linux-based computers for use with 3D MRI scans.

NeuroQuant^® has been cleared for marketing as a medical device by the US FDA [510(k) K061855]. Analysis performed with NeuroQuant^® may be appropriate for billing under existing CPT code for 3D volumetric image post-processing (76377).

CorTechs has received SBIR funding from the US National Institute of Aging to evaluate use of NeuroQuant^® to quantify atrophy in patients with neurodegenerative disease. Example application of NeuroQuant^® to a sample of data from normal control subjects, patients with mild cognitive impairment, and patients with probably Alzheimer's disease who are participating in the NIH and pharma-industry cosponsored Alzheimer's Disease Neuroimaging Initiative (ADNI) trial can be seen here.

Note to FreeSurfer users: CorTechs Labs shares copyright ownership of FreeSurfer (http://surfer.nmr.mgh.harvard.edu/) with Massachusetts General Hospital. Like NeuroQuant^®, Freesurfer performs automated segmentation and quantification of selected brain structures from MRI. However, FreeSurfer is not an FDA-cleared product and its End User License Agreement (EULA) expressly prohibits its use in clinical diagnosis. The EULA also prohibits FreeSurfer use by for-profit organizations or in research sponsored by such organizations. In contrast, NeuroQuant^® is FDA-cleared for clinical use and is available to for-profit as well as nonprofit organizations.